Job/Unit: O43299
/KAP1
Date: 11-12-14 11:37:53
Pages: 8
L. George, Z. Ahmed, H. Lemmetyinen, A. Efimov
FULL PAPER
with water (twice), dried with Na2SO4, and concentrated. The
crude product was purified through silica gel with dichloromethane
as the eluent to yield 4 (83 mg, 68%) as a dark red solid. 1H NMR
(300 MHz, CDCl3, TMS): δ = 8.36–8.39 (d, J = 7.92 Hz, 2 H), 8.13
150.01, 149.95, 143.88, 143.86, 136.05, 136.03, 133.59, 133.56,
132.96, 132.93, 131.45, 130.93, 130.67, 128.87, 128.83, 128.73,
128.68, 127.79, 127.67, 126.19, 126.01, 123.34, 123.24, 118.08,
117.93, 117.36, 117.12, 52.21, 35.58, 35.56, 34.23, 31.86, 31.83,
(t, J = 8.50 Hz, 4 H), 7.95–7.97 (d, J = 7.92 Hz, 2 H), 4.36 (t, J = 31.25, 31.23, 29.69, 25.72 ppm. HRMS (ESI-TOF): calcd. for
6.74 Hz, 4 H), 4.16 (t, J = 7.62 Hz, 2 H), 1.67–1.94 (m, 6 H), 1.20–
1.64 (m, 15 H), 1.02 (t, J = 7.33 Hz, 6 H), 0.88 (s, 3 H) ppm. 13C
NMR (75 MHz, CDCl3, TMS): δ = 168.44, 163.58, 135.24, 132.04,
132.00, 131.27, 130.39, 129.24, 129.03, 128.99, 122.59, 125.83,
122.16, 121.77, 65.81, 56.56, 40.80, 32.08, 30.86, 29.60, 29.51,
28.37, 27.45, 22.89, 19.51, 14.36, 14.06, 9.60, 0.23 ppm. HRMS
(ESI-TOF): calcd. for C40H43NO6 [M]+ 633.3085; found 633.3068.
C60H64N4O4 [M]+ 904.4922; found 904.4949.
2,9-Bis(2,5-di-tert-butylphenyl)-5,13-di(piperidin-1-yl)isoquinolino-
[4Ј,5Ј,6Ј:6,5,10]anthra[2,1,9-def]isoquinoline-1,3,8,10(2H,9H)-tetrone
(6bЈ): The general procedure for the direct amination was followed
by stirring 1Ј (0.013 mmol, 10 mg), AgNO3 (0.13 mmol, 22 mg),
and powdered KMnO4 (0.13 mmol, 21 mg) in piperidine (1.5 mL)
for 24 h at room temperature to give 6bЈ (60%, 7.3 mg) as a dark
blue solid. 1H NMR (300 MHz, CDCl3, TMS): δ = 9.81 (d, J =
8.50 Hz, 2 H), 8.68 (d, J = 8.50 Hz, 2 H), 8.46 (s, 2 H), 7.62–7.59
(m, 2 H), 7.49–7.44 (m, 2 H), 7.02–6.98 (m, 2 H), 3.48–3.38 (m, 4
H), 2.98–2.87 (m, 4 H), 1.92–1.74 (m, 12 H), 1.35–1.32 (m, 36 H)
ppm. 13C NMR (75 MHz, CDCl3, TMS): δ = 164.80, 164.69,
153.45, 150.09, 150.01, 143.91, 143.82, 136.42, 136.39, 133.21,
132.74, 132.09, 131.17, 129.35, 128.77, 128.72, 128.30, 127.74,
127.58, 126.26, 126.15, 123.87, 123.57, 123.46, 122.86, 121.16,
120.58, 53.20, 53.08, 35.56, 34.25, 33.70, 31.93, 31.83, 31.25, 31.23,
30.16, 29.71, 29.37, 26.70, 25.87, 23.77, 22.70 ppm. HRMS (ESI-
TOF): calcd. for C62H68N4O4 [M]+ 932.5235; found 932.5287.
2,9-Dioctyl-5-(pyrrolidin-1-yl)isoquinolino[4Ј,5Ј,6Ј:6,5,10]anthra-
[2,1,9-def]isoquinoline-1,3,8,10(2H,9H)-tetrone (5a): Pyrrolidine
(20 mL) was bubbled with argon for 5 min, and 1 (0.0138 mmol,
8.5 mg) was added. The resultant mixture was again purged with
argon for 1 min and heated at 60 °C for 5 h. A pyridinium dichro-
mate solution (0.138 mmol, 5.3 mg dissolved in pyrrolidine and
purged with argon for 5 min) was added to the reaction mixture,
which was then stirred for 5 min. The reaction was quenched with
water (20 mL), extracted with chloroform (three times), dried with
Na2SO4, and concentrated. The crude product was purified by TLC
(neutral aluminum oxide 60 F254 TLC plates with dichloromethane
as eluent) to yield 5a as a green solid (7.2 mg, 70%). 1H NMR
(300 MHz, CDCl3, TMS): δ = 8.57–8.64 (m, 2 H), 8.29–8.49 (m, 4
H), 7.39–7.57 (m, 1 H), 4.09–4.31 (m, 4 H), 3.58–3.83 (m, 2 H),
2.74 (br s, 2 H), 1.88–2.23 (m, 4 H), 1.65–1.86 (m, 4 H), 1.23–1.52
(m, 21 H), 0.88 (t, J = 6.74 Hz, 6 H) ppm. 13C NMR (75 MHz,
CDCl3, TMS): δ = 163.87, 163.81, 163.71, 163.65, 148.40, 135.42,
135.18, 132.59, 130.95, 130.68, 128.93, 128.59, 127.11, 124.19,
126.56, 123.68, 122.98, 122.56, 122.33, 121.62, 120.41, 118.96,
115.83, 52.42, 40.67, 40.58, 31.86, 31.85, 29.42, 29.37, 29.28, 29.25,
28.18, 27.24, 27.18, 25.78, 22.66, 14.12 ppm. HRMS (ESI-TOF):
calcd. for C44H49N3O4 [M]+ 683.3718; found 683.3740.
Dibutyl 2-Octyl-1,3-dioxo-6-(pyrrolidin-1-yl)-2,3-dihydro-1H-benzo-
[5,10]anthra[2,1,9-def]isoquinoline-8,9-dicarboxylate (7a) and Di-
butyl 2-Octyl-1,3-dioxo-6,11-di(pyrrolidin-1-yl)-2,3-dihydro-1H-
benzo[5,10]anthra[2,1,9-def]isoquinoline-8,9-dicarboxylate (7b): The
general procedure for the direct amination was followed by stirring
4 (0.0946 mmol, 60 mg), AgNO3 (0.945 mmol, 160 mg), and pow-
dered KMnO4 (0.945 mmol, 150 mg) in pyrrolidine (1.5 mL) for
24 h at room temperature to give 7a (40 mg, 60%) and 7b (14.2 mg,
20%) as dark solids.
Data for 7a: 1H NMR (300 MHz, CDCl3, TMS): δ = 8.68–8.49 (m,
2 H), 8.46–8.27 (m, 2 H), 8.00 (s, 1 H), 7.95 (d, J = 8.05 Hz,1 H),
7.15 (d, J = 8.05 Hz, 1 H), 4.44–4.29 (m, 4 H), 4.26–4.16 (m, 2 H),
3.83–3.67 (m, 2 H), 3.67–3.61 (m, 2 H), 2.87–2.65 (m, 2 H), 2.18–
2.00 (m, 2 H), 2.00–1.88 (m, 2 H), 1.87–1.69 (m, 6 H), 1.60–1.39
(m, 8 H), 1.39–1.21 (m, 10 H), 1.02 (t, J = 7.24 Hz, 3 H), 0.98 (t,
J = 7.24 Hz, 3 H), 0.91–0.84 (m, 3 H) ppm. 13C NMR (75 MHz,
CDCl3, TMS): δ = 169.07, 168.10, 164.29, 164.16, 147.91, 136.52,
131.43, 131.26, 131.15, 131.02, 130.46, 129.26, 127.03, 126.17,
123.47, 122.69, 121.96, 120.73, 119.60, 117.58, 111.76, 70.77, 65.72,
65.66, 52.73, 40.68, 32.09, 30.92, 30.82, 29,92, 29.66, 29.50, 28.43,
27.48, 25.93, 22.89, 19.50, 19.48, 14.34, 14.06, 14.04 ppm. HRMS
(ESI-TOF): calcd. for C44H50N2O6 [M]+ 702.3663; found 702.3704.
2,9-Dioctyl-5,13-di(pyrrolidin-1-yl)isoquinolino[4Ј,5Ј,6Ј:6,5,10]-
anthra[2,1,9-def]isoquinoline-1,3,8,10(2H,9H)-tetrone (5b): The
compound was prepared by following the general procedure for the
direct amination of peryleneimides. Compound 1 (0.0325 mmol,
20 mg) was stirred with silver nitrate (0.0516 mmol, 8.7 mg) in pyr-
rolidine (5 mL). Powdered KMnO4 (0.0516 mmol, 8.2 mg) was
added to the reaction mixture, which was then stirred for 24 h to
afford 5b (65%, 15.8 mg) as a dark blue solid. 1H NMR (300 MHz,
CDCl3, TMS): δ = 8.68 (d, J = 7.92 Hz, 2 H), 8.34 (s, 2 H), 7.86
(d, J = 8.21 Hz, 2 H), 4.13–4.36 (m, 4 H), 3.56–3.91 (m, 4 H), 2.77
(br s, 3 H), 1.87–2.23 (m, 8 H), 1.67–1.86 (m, 4 H), 1.13–1.53 (m,
30 H), 0.87 (t, J = 6.74 Hz, 9 H) ppm. 13C NMR (75 MHz, CDCl3,
TMS): δ = 164.65, 164.35, 150.24, 135.94, 131.28, 130.45, 128.73,
128.47, 123.52, 123.11, 117.99, 117.80, 117.19, 117.10, 52.40, 40.87,
40.69, 32.09, 32.06, 29.93, 29.68, 29.59, 29.49, 29.46, 28.49, 28.44,
27.49, 27.38, 25.90, 22.89, 14.34 ppm. HRMS (ESI-TOF): calcd.
for C48H56N4O4 [M]+ 752.4296; found 752.4291.
1
Data for 7b: H NMR (300 MHz, CDCl3, TMS): δ = 8.65 (t, J =
7.92 Hz, 2 H), 7.83 (s, 2 H), 7.51 (t, J = 7.92 Hz, 2 H), 4.33 (t, J =
7.04 Hz, 4 H), 4.24 (t, J = 7.33 Hz, 2 H), 3.90–3.50 (m, 4 H), 3.02–
2.52 (m, 4 H), 1.84–1.71 (m, 6 H), 1.55–1.40 (m, 8 H), 0.99 (t, J =
7.33 Hz, 6 H), 0.93–0.79 (m, 3 H) ppm. 13C NMR (75 MHz,
CDCl3, TMS): δ = 168.65, 164.57, 149.95, 136.62, 132.95, 131.30,
130.34, 128.61, 128.46, 122.89, 116.45, 116.34, 115.89, 112.60,
65.63, 52.61, 40.61, 32.11, 30.88, 29.93, 29.70, 29.51, 28.52, 27.51,
25.97, 22.89, 19.49, 14.35, 14.07 ppm. HRMS (ESI-TOF): calcd.
for C48H57N3O6 [M]+ 771.4242; found 771.4203.
2,9-Bis(2,5-di-tert-butylphenyl)-5,13-di(pyrrolidin-1-yl)isoquinolino-
[4Ј,5Ј,6Ј:6,5,10]anthra[2,1,9-def]isoquinoline-1,3,8,10(2H,9H)-tetrone
(5bЈ): The general procedure for the direct amination was followed
by stirring 1Ј (0.026 mmol, 20 mg), AgNO3 (0.26 mmol, 44 mg),
and powdered KMnO4 (0.26 mmol, 41 mg) in pyrrolidine (3 mL)
for 24 h at room temperature to give 5bЈ (69%, 16.3 mg) as a dark
blue solid. 1H NMR (300 MHz, CDCl3, TMS): δ = 8.76 (d, J =
8.21 Hz, 2 H), 8.41 (s, 2 H), 7.92 (dd, J = 8.21 Hz, 2 H), 7.63–7.59
(m, 2 H), 7.49–7.44 (m, 2 H), 7.03–7.00 (m, 2 H), 3.77 (br, 3 H),
Dibutyl 2-Octyl-1,3-dioxo-6-(piperidin-1-yl)-2,3-dihydro-1H-benzo-
[5,10]anthra[2,1,9-def]isoquinoline-8,9-dicarboxylate (8a) and Di-
butyl 2-Octyl-1,3-dioxo-6,11-di(piperidin-1-yl)-2,3-dihydro-1H-
benzo[5,10]anthra[2,1,9-def]isoquinoline-8,9-dicarboxylate (8b): The
general procedure for the direct amination was followed by stirring
2.86 (br, 3 H), 2.05 (br, 8 H), 1.36–1.33 (m, 36 H) ppm. 13C NMR 4 (0.0.032 mmol, 20.5 mg), AgNO3 (0.32 mmol, 53 mg), and pow-
(75 MHz, CDCl3, TMS): δ = 165.38, 165.17, 150.08, 150.03, dered KMnO4 (0.32 mmol, 50 mg) in piperidine (3 mL) for 24 h at
6
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0